Women s Interagency HIV Study (WIHS) IV, Limited Competition (U01)

The summary for the Women s Interagency HIV Study (WIHS) IV, Limited Competition (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Women s Interagency HIV Study (WIHS) IV, Limited Competition (U01)
	CFDA Number:	93.27993.393
	CFDA Description:	Drug Abuse and Addiction Research Programs 93.393 Cancer Cause and Prevention Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Income Security and Social Services Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-AI-07-004
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Dec 27, 2006
	Creation Date:	Dec 27, 2006
	Original Closing Date for Applications:	Mar 14, 2007
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Apr 13, 2007
	Expected Number of Awards:	7
	Estimated Total Program Funding:	$20,000,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	93.394 -- Cancer Detection and Diagnosis Research

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Foreign institutions are not eligible to apply. Applications may be submitted by the seven awardees the current six WIHS clinical sites and the WIHS Data Management and Analysis Center (WDMAC). The seven cooperative agreement numbers, geographic locations, principal investigators, and awardee institutions are: WIHS Clinical Sites: U01 AI 35004, Bronx, NY (PI: Dr. Kathryn Anastos, Montefiore Medical Center) U01 AI 31834, Brooklyn, NY (PI: Dr. Howard Minkoff, SUNY Downstate Medical Center) U01 AI 34993, Chicago, IL (PI: Dr. Mardge Cohen, Hektoen Institute for Medical Research) U01 HD 32632, Los Angeles, CA (PI: Dr. Alexandra Levine, University of Southern California) U01 AI 34989, San Francisco, CA (PI: Dr. Ruth Greenblatt, University of California San Francisco) U01 AI 34994, Washington, DC (PI: Dr. Mary Young, Georgetown University) WIHS Data Management and Analysis Center (WDMAC): U01 AI 42590, Baltimore, MD, (PI: Dr. Stephen Gange, Johns Hopkins University)
Grant Description: -This limited competition RFA solicits applications to continue projects currently funded at the seven sites for the Women s Interagency HIV Study (WIHS) for a 5-year period beginning November 1, 2007. The WIHS is a multi-site prospective epidemiology cohort study of women in the United States who are either infected with HIV or at increased risk for such infections. The WIHS cohort was established in 1994 and has participated in follow-up visits at six-month intervals since that time. The study is currently funded by the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Child Health and Human Development (NICHD), the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI). Due to the longitudinal data collected and need for continuing follow-up, competition will be restricted to the seven current WIHS institutions. -The specific objective and scope for continuing the WIHS Study is to address research questions on the natural and treated history of HIV infection in a representative cohort of women in the United States as well as emerging questions concerning HIV infection and treatment. The WIHS, by prospectively studying a cohort of predominantly minority women with or at high risk for HIV infection, is providing detailed information relevant to the evolving biological and psychosocial characteristics of the HIV/AIDS epidemic in U.S. women as we move into a second decade of antiretroviral therapy. -This RFA will use the U01 (Cooperative Agreement) mechanism.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-07-004.html http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-07-004.html
Grant Announcement Contact: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster